ENDRA Life Sciences (NDRA) Receivables - Other (2024)

ENDRA Life Sciences (NDRA) posted quarterly Receivables - Other of $799284.0 for Q4 2024, down 12.22% quarter-over-quarter from $910556.0 in Q3 2024.

ENDRA Life Sciences (NDRA) Receivables - Other (2024) Analysis & Trends

ENDRA Life Sciences (NDRA) has reported Receivables - Other for 1 consecutive years, with $799284.0 the latest figure, recorded in Q4 2024.

In Q4 2024, Receivables - Other changed N/A year-over-year to $799284.0; the TTM figure through Dec 2024 stood at $799284.0 (changed N/A YoY), while the FY2024 annual figure was $799284.0, changed N/A from the prior year.
Receivables - Other fell to $799284.0 in Q4 2024 per NDRA's latest filing, from $910556.0 in the prior quarter.
Across five years, Receivables - Other topped out at $910556.0 in Q3 2024 and bottomed at $799284.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	ENDRA Life Sciences	7.16 Mn	1.62 Mn	-

Download Data